HIV Treatment Retention Interventions for Women Living With HIV (Siyaphambili Study)

NACompletedINTERVENTIONAL
Enrollment

1,391

Participants

Timeline

Start Date

June 22, 2018

Primary Completion Date

November 24, 2021

Study Completion Date

January 5, 2022

Conditions
HIV-1 Virologic Response
Interventions
BEHAVIORAL

DTP

Provision of antiretroviral therapy (ART) in the community through a mobile-van DTP managed by a nurse capable of initiating and managing ART.

BEHAVIORAL

ICM

Peer-led ICM through quarterly face-to-face meetings, monthly phone calls and biweekly text messages.

Trial Locations (1)

Unknown

TB HIV Care, Durban

All Listed Sponsors
collaborator

University of the Western Cape

OTHER

collaborator

TB HIV Care

OTHER

collaborator

University of Toronto

OTHER

collaborator

University of California, San Francisco

OTHER

collaborator

National Institute for Communicable Diseases, South Africa

OTHER

lead

Johns Hopkins Bloomberg School of Public Health

OTHER

NCT03500172 - HIV Treatment Retention Interventions for Women Living With HIV (Siyaphambili Study) | Biotech Hunter | Biotech Hunter